insights_auto
Zašto je RCEL skočio 2,61%?
Istražite detaljnijechevron_right
RCEL:NASDAQ
AVITA Medical Inc
16,50 USD
arrow_upward
+2,61%(+0,42) 1D
28. lis, 15:44:31 GMT -4 · USD
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za RCEL...
Otvori
15,82 USD
Najviša
16,68 USD
Najniža
15,68 USD
Trž. kap.
510,29 mil.
Prosj. kol.
379,78 tis.
Količina
377,71 tis.
52-tjed. najviša
16,68 USD
52-tjed. najniža
3,22 USD
EPS
−1,44 USD
Beta
1,99
Dionice u optjecaju
30,93 mil.
Broj djelatnika
226
Otvori
15,82 USD
Najviša
16,68 USD
Najniža
15,68 USD
Trž. kap.
510,29 mil.
Prosj. kol.
379,78 tis.
Količina
377,71 tis.
52-tjed. najviša
16,68 USD
52-tjed. najniža
3,22 USD
EPS
−1,44 USD
Beta
1,99
Dionice u optjecaju
30,93 mil.
Broj djelatnika
226
Vijesti
Iz web-izvora i od partnera za vijesti
Kalkine
·
prije 1 dan
AVITA Medical Inc. (ASX:AVH): How Did Q2 Revenue and Wound-Care Product Sales Develop?
Yahoo Finance
·
prije 2 dana
What AVITA Medical Holders Bought Into Before A 347% Run
Profil
Avita Medical is a clinical and commercial company developing and marketing a range of regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are PermeaDerm, a transparent, biosynthetic bilayer wound matrix used for temporary wound coverage after surgical excision of burns or trauma, and Cohealyx, a bovine-derived collagen dermal matrix used by burn and trauma surgeons to treat severe wounds and full-thickness burns by accelerating blood vessel formation in order to prepare damaged wound beds for skin autografts. Wikipedia
AVITA Medical Inc – informacije
Glavni izvršni direktorJames Corbett
Zaposlenici226
Osnovano1999
SjedišteValencia, Kalifornija, Sjedinjene Američke Države
Sektor-
Web-lokacijaavitamedical.com